Keyword: Type 2 Diabetes
2 results found.
Congress Abstract
Central Asian Journal of Nephrology, 2(2, Suppl. 1), 2026, cajn_A24, https://doi.org/10.63946/cajn/19514
ABSTRACT:
Background: Patients with type 2 diabetes mellitus (T2DM) on maintenance hemodialysis represent one of the highest-risk populations in nephrology practice. End-stage kidney disease (ESKD) and T2DM create a state of profound immunosuppression that predisposes patients to life-threatening infections.
Central venous catheters (CVCs), frequently required for hemodialysis access, are a well-recognized gateway for bacteremia. When bacteremia is complicated by coagulopathy, the clinical course can rapidly evolve toward disseminated intravascular coagulation (DIC).
Case Presentation: A 58-year-old woman was admitted with a 3-day history of nausea, vomiting, and body pain. Examination revealed anasarca, lower-extremity purpura, and petechial rash, with concern for coagulopathy. T2DM diagnosed in 2007 and ESKD on maintenance hemodialysis since October 2025 (three 4-hour sessions weekly). Vascular access was a right internal jugular CVC.
On admission, hemoglobin 62 g/L, RBC 2.02 ×10¹²/L, platelets 93 ×10⁹/L, WBC 11.18 ×10⁹/L, glucose 24.28 mmol/L, total protein 63 g/L, D-dimer 2,680 ng/mL, procalcitonin (PCT) 14.8 ng/mL, creatinine 405 μmol/L, urea 13.9 mmol/L, INR 1.46, Prothrombin Index 66%, fibrinogen 4.0 g/L, APTT 28.2 sec. Antibiotics had been started at home without improvement. In hospital, broad-spectrum therapy was escalated to a carbapenem plus a fluoroquinolone, with packed red blood cell and fresh frozen plasma transfusions. Hemoglobin increased to 87 g/L, PCT decreased to 1.78 ng/mL, and D-dimer to 1,178 ng/mL; thrombocytopenia persisted. After treatment, creatinine 592 μmol/L, urea 20.7 mmol/L, glucose 16.55 mmol/L, albumin 26 g/L, total protein 53 g/L, INR 1.39, Prothrombin Index 69%, fibrinogen 7.55 g/L, APTT 25.4 sec.
On days 5–6, livedo reticularis, worsening dyspnea, and persistent coagulopathy prompted chest MSCT. It revealed bilateral peribronchial foci with formed cavities, consistent with abscessing (necrotizing) pneumonia. The bilateral cavitary pattern suggested hematogenous dissemination, likely from the indwelling CVC. Patient transferred to the ICU with sepsis-associated DIC.
Linezolid 600 mg IV twice a day was added to provide coverage for possible methicillin-resistant Staphylococcus aureus and other gram-positive organisms. Following treatment escalation, hemoglobin reached 118 g/L, PCT decreased to 0.9 ng/mL, INR normalized to 0.92, and Prothrombin Index increased to 117%.
Conclusion: CVC-related bacteremia should be considered early in hemodialysis patients with unexplained coagulopathy or bilateral pulmonary infiltrates. Purpura followed by livedo reticularis may indicate DIC progression and should prompt urgent reassessment. Cavitation despite antibiotics signals treatment failure and need to reassess pathogen coverage, including biofilm-forming gram-positive organisms. T2DM and ESKD create a multiplicative immunocompromised state, requiring multimodal management and glycemic control.
Central venous catheters (CVCs), frequently required for hemodialysis access, are a well-recognized gateway for bacteremia. When bacteremia is complicated by coagulopathy, the clinical course can rapidly evolve toward disseminated intravascular coagulation (DIC).
Case Presentation: A 58-year-old woman was admitted with a 3-day history of nausea, vomiting, and body pain. Examination revealed anasarca, lower-extremity purpura, and petechial rash, with concern for coagulopathy. T2DM diagnosed in 2007 and ESKD on maintenance hemodialysis since October 2025 (three 4-hour sessions weekly). Vascular access was a right internal jugular CVC.
On admission, hemoglobin 62 g/L, RBC 2.02 ×10¹²/L, platelets 93 ×10⁹/L, WBC 11.18 ×10⁹/L, glucose 24.28 mmol/L, total protein 63 g/L, D-dimer 2,680 ng/mL, procalcitonin (PCT) 14.8 ng/mL, creatinine 405 μmol/L, urea 13.9 mmol/L, INR 1.46, Prothrombin Index 66%, fibrinogen 4.0 g/L, APTT 28.2 sec. Antibiotics had been started at home without improvement. In hospital, broad-spectrum therapy was escalated to a carbapenem plus a fluoroquinolone, with packed red blood cell and fresh frozen plasma transfusions. Hemoglobin increased to 87 g/L, PCT decreased to 1.78 ng/mL, and D-dimer to 1,178 ng/mL; thrombocytopenia persisted. After treatment, creatinine 592 μmol/L, urea 20.7 mmol/L, glucose 16.55 mmol/L, albumin 26 g/L, total protein 53 g/L, INR 1.39, Prothrombin Index 69%, fibrinogen 7.55 g/L, APTT 25.4 sec.
On days 5–6, livedo reticularis, worsening dyspnea, and persistent coagulopathy prompted chest MSCT. It revealed bilateral peribronchial foci with formed cavities, consistent with abscessing (necrotizing) pneumonia. The bilateral cavitary pattern suggested hematogenous dissemination, likely from the indwelling CVC. Patient transferred to the ICU with sepsis-associated DIC.
Linezolid 600 mg IV twice a day was added to provide coverage for possible methicillin-resistant Staphylococcus aureus and other gram-positive organisms. Following treatment escalation, hemoglobin reached 118 g/L, PCT decreased to 0.9 ng/mL, INR normalized to 0.92, and Prothrombin Index increased to 117%.
Conclusion: CVC-related bacteremia should be considered early in hemodialysis patients with unexplained coagulopathy or bilateral pulmonary infiltrates. Purpura followed by livedo reticularis may indicate DIC progression and should prompt urgent reassessment. Cavitation despite antibiotics signals treatment failure and need to reassess pathogen coverage, including biofilm-forming gram-positive organisms. T2DM and ESKD create a multiplicative immunocompromised state, requiring multimodal management and glycemic control.
Original Article
Central Asian Journal of Nephrology, 2(1), 2026, cajn012, https://doi.org/10.63946/cajn/18298
ABSTRACT:
Background: To evaluate diabetic kidney disease (DKD) knowledge, attitudes, and practices (KAP) among adults with type 2 diabetes (T2D) in southern Kyrgyzstan.
Methods: A cross-sectional survey assessed DKD KAP among adults with T2D recruited from public healthcare facilities in Osh, Kyrgyzstan. We used a structured questionnaire guided by the Health Belief Model and the Health Locus of Control. We used multiple linear regression models to examine factors associated with KAP scores.
Results: A total of 207 adults participated (mean age 61.0 ± 10.7 years; 61.4% female). Although 91.3% identified healthcare workers as their most trusted information source, only 49.3% reported receiving DKD-related information from a healthcare provider. Only 13.5% recognized that early kidney damage does not cause pain. Despite generally positive attitudes towards kidney protective behaviors, 72.9% of participants reported low personal control over their health outcomes. In adjusted models, prior receipt of provider DKD information was the sole factor consistently associated with higher knowledge (β = 1.25, 95% CI 0.43–2.08, p = 0.003), attitudes (β = 3.11, 95% CI 1.61–4.61, p < 0.001), and practices (β = 3.99, 95% CI 2.26–5.71, p < 0.001).
Conclusion: Adults with T2D in southern Kyrgyzstan experience significant knowledge gaps and misconceptions regarding kidney protection, despite high trust and willingness to learn from healthcare providers. Prior provider-delivered information was associated with better practices, highlighting the need for structured DKD counseling that explicitly addresses misconceptions and aligns health messages with local beliefs to strengthen self-efficacy.
Methods: A cross-sectional survey assessed DKD KAP among adults with T2D recruited from public healthcare facilities in Osh, Kyrgyzstan. We used a structured questionnaire guided by the Health Belief Model and the Health Locus of Control. We used multiple linear regression models to examine factors associated with KAP scores.
Results: A total of 207 adults participated (mean age 61.0 ± 10.7 years; 61.4% female). Although 91.3% identified healthcare workers as their most trusted information source, only 49.3% reported receiving DKD-related information from a healthcare provider. Only 13.5% recognized that early kidney damage does not cause pain. Despite generally positive attitudes towards kidney protective behaviors, 72.9% of participants reported low personal control over their health outcomes. In adjusted models, prior receipt of provider DKD information was the sole factor consistently associated with higher knowledge (β = 1.25, 95% CI 0.43–2.08, p = 0.003), attitudes (β = 3.11, 95% CI 1.61–4.61, p < 0.001), and practices (β = 3.99, 95% CI 2.26–5.71, p < 0.001).
Conclusion: Adults with T2D in southern Kyrgyzstan experience significant knowledge gaps and misconceptions regarding kidney protection, despite high trust and willingness to learn from healthcare providers. Prior provider-delivered information was associated with better practices, highlighting the need for structured DKD counseling that explicitly addresses misconceptions and aligns health messages with local beliefs to strengthen self-efficacy.